Overexpression of prostate cancer-associated SPOP mutants (e.g., Y87C, and F133V) increased the amount of TOP2A, but not TOP1, in the nuclei as well as the drastic accumulation of γH2AX in the nuclei [38]. This evidence concerns the gene SPOP and prostate carcinoma.